With the development of the anti-hypertensive Maxzide ®, Mylan became the first generic pharmaceutical manufacturer to patent a new drug, celebrated its 25-year anniversary and became a member of The New York Stock Exchange.
Mylan became the first generic pharmaceutical manufacturer. This was with the development of the anti-hypertensive Maxzide ®. This was to patent a new drug. Mylan celebrated its 25-year anniversary. This was with the development of the anti-hypertensive Maxzide ®. Mylan became a member of The New York Stock Exchange. This was with the development of the anti-hypertensive Maxzide ®.